Keyphrases
Peru
100%
Lima
97%
Escherichia Coli Strains
92%
Enterotoxigenic Escherichia Coli
89%
Peruvian
78%
Diarrhea
71%
Stx2
47%
Escherichia Coli Isolates
47%
Shiga Toxin-producing Escherichia Coli
42%
Diarrheagenic E. Coli
41%
Escherichia Coli
38%
Virulence Factors
37%
Genotypic Characterization
35%
Norovirus
35%
Human Endothelial Cells
35%
Miglustat
35%
Human Epithelial Cells
35%
Renal Damage
35%
Colonization Factors
30%
Peri-urban
23%
Enterotoxigenic E. Coli
20%
Stx1
19%
Suburban Area
17%
Healthy Cattle
17%
Healthy pigs
17%
Communication Detection
17%
Travelers' Diarrhea
17%
Short Communication
17%
Adhesion Pattern
17%
Colonization Factor Antigens
17%
Gangliosides
17%
Cholera Toxin
17%
Regulatory Approach
17%
Intestinal Fluid Accumulation
17%
Administrative Approach
17%
Social Health Insurance
17%
Surface Antigen
17%
Phylogenetic Relationship
17%
Gastroenteritis
17%
Comparative Analysis
17%
Antimicrobial Resistance
17%
Bovine Lactoferrin
17%
Clinical Trials
17%
Pediatric Population
17%
High Prevalence
17%
Pediatric Patients
17%
Phenotypic Characterization
17%
Mixed Infection
17%
Diffusely Adherent Escherichia Coli
17%
Quinolone Resistance
17%
Pharmacology, Toxicology and Pharmaceutical Science
Enterotoxigenic Escherichia Coli
71%
Escherichia coli
61%
Diarrhea
50%
Miglustat
35%
Kidney Injury
35%
Shiga Toxin
35%
Prevalence
29%
Receptor
25%
Cytotoxicity
23%
Diarrheagenic Escherichia Coli
19%
Cohort Study
19%
Mixed Infection
17%
Norovirus
17%
Quinolone
17%
Traveller Diarrhea
17%
Cholera Toxin
17%
Ganglioside
17%
Antimicrobial Resistance
17%
Lactoferrin
17%
Clinical Trial
17%
Antibiotic Resistance
17%
Infectious Agent
17%
Nalidixic Acid
13%
Virulence Factor
13%
Escherichia Coli O157
11%
Glucosylceramide
11%
Cellular Injury
11%
Acute Kidney Failure
11%
Synthetase
11%
Primary Culture
11%
Hemolytic Uremic Syndrome
11%
Chronic Kidney Failure
11%
Actin
7%
Ganglioside GM1
7%
Ciprofloxacin
6%
Enteropathogenic Escherichia Coli
5%
Enteroaggregative Escherichia Coli
5%
Immunology and Microbiology
Escherichia coli
98%
Enterotoxigenic Escherichia Coli
53%
Diarrheagenic Escherichia Coli
41%
Verotoxin-Producing Escherichia Coli
41%
Prevalence
29%
Bovine
17%
Membrane Antigen
17%
Antimicrobial Resistance
17%
Human Immunodeficiency Virus
17%
Minimum Inhibitory Concentration
17%
Cladistics
17%
Real Time Polymerase Chain Reaction
12%
Infectious Agent
8%
Serotype
8%
Enteropathogenic Escherichia Coli
8%
Actin
7%
Actin Polymerization
7%
Disk Diffusion
6%
Phylogeny
5%
Multilocus Sequence Typing
5%
Enteroaggregative Escherichia Coli
5%